Methodological and Policy Limitations of Quantifying the Saving of Lives: A Case Study of the Global Fund's Approach
article has not abstract
Vyšlo v časopise:
Methodological and Policy Limitations of Quantifying the Saving of Lives: A Case Study of the Global Fund's Approach. PLoS Med 10(10): e32767. doi:10.1371/journal.pmed.1001522
Kategorie:
Policy Forum
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001522
Souhrn
article has not abstract
Zdroje
1. GAVI Alliance (2012) GAVI's Impact. Available: http://www.gavialliance.org/about/mission/impact/. Accessed 10 May 2013.
2. World Bank (2012) World Bank: Health: Sector Results Profile. Available: http://web.worldbank.org/WBSITE/EXTERNAL/NEWS/0,contentMDK:22883311~menuPK:64256345~pagePK:34370~piPK:34424~theSitePK:4607,00.html. Accessed 26 September 2012.
3. United States President's Emergency Plan for AIDS Relief (2012) AIDS 2012 Update: Latest PEPFAR Results. Available: http://www.pepfar.gov/funding/results/index.htm. Accessed 10 May 2013.
4. World Health Organization (2012) Global Tuberculosis Report 2012. Available: http://www.who.int/tb/publications/global_report/en/. Accessed 7 May 2013.
5. EiseleTP, LarsenDA, WalkerN, CibulskisRE, YukichJO, et al. (2012) Estimates of child deaths prevented from malaria prevention scale-up in Africa 2001–2010. Malar J 11: 93 doi: 10.1186/1475-2875-11-93. Available: http://www.malariajournal.com/content/pdf/1475-2875-11-93.pdf. Accessed 10 May 2013
6. World Health Organization, UNAIDS, UNICEF (2011) Global HIV/AIDS response. Epidemic update and health sector progress towards Universal Access. Progress report 2011. Available: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/20111130_UA_Report_en.pdf. Accessed 10 May 2013.
7. Global Fund to Fight AIDS, Tuberculosis and Malaria, (2012) Strategic Investments for Impact. Global Fund Results Report 2012. Available: http://www.theglobalfund.org/en/library/publications/progressreports/. Accessed 10 May 2013.
8. KomatsuR, KorenrompEL, Low-BeerD, WattC, DyeC, et al. (2010) Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: Estimation approach and results between 2003 and end-2007. BMC Infect Dis 10: 109 Available: http://www.biomedcentral.com/1471-2334/10/109. Accessed 10 May 2013.
9. Global Fund (2012) Attachment 3. Background Information on Goals and Targets for the Global Fund Strategy 2012–2016. Available: http://www.theglobalfund.org/en/about/strategy. Accessed 10 May 2013.
10. Global Fund (2011) The Global Fund Results Report 2011: Making a Difference. Available: http://www.theglobalfund.org/en/library/publications/progressreports/. Accessed 14 October 2012.
11. MahyM, StoverJ, StaneckiK, StoneburnerR, TassieJM (2010) Estimating the impact of antiretroviral therapy: regional and global estimates of life-years gained among adults. Sex Transm Infect 86 (Suppl 2) ii67–71.
12. YiannoutsosCY, JohnsonLF, BoulleA, MusickBS, GsponerT, et al. (2012) Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy. Sex Transm Infect 88 (Suppl 2): i33–i43 doi:10.1136/sextrans-2012-050658. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512431/. Accessed 10 May 2013
13. RollinsN, MahyM, BecquetR, KuhnL, CreekT, et al. (2012) Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models. Sex Transm Infect 88 (Suppl 2): i44–i51 doi:10.1136/sextrans-2012-050709. Available: http://www.emtct-iatt.org/wp-content/uploads/2013/06/Estimates-of-peripartum-and-postnatal-mother-to-child-transmission-probabilities-of-HIV-for-use-in-Spectrum-and-other-population-based-models.pdf. Accessed 10 May 2013
14. Mahy M (2012) Personal communication.
15. TiemersmaEW, van der WerfMJ, BorgdorffMW, WilliamsBG, NagelkerkeNJ (2011) Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: A systematic review. PLoS ONE 6: e17601 Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0017601. Accessed 10 May 2013
16. GlaziouP, FloydK, KorenrompEL, SismanidisB, BierrenbachA, et al. (2011) Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reductions in tuberculosis mortality. Bull World Health Organ 89: 573–582 Available: http://www.who.int/bulletin/volumes/89/8/11-087510.pdf. Accessed 10 May 2013.
17. StraetemansM, BierrenbachAL, NagelkerkeN, GlaziouP, van der WerfMJ (2010) The effect of tuberculosis on mortality in HIV positive people: a meta-analysis. PLoS ONE 5: e15241 Available: http://www.plosone.org/article/info:doi/10.1371/journal.pone.0015241?imageURI=info:doi/10.1371/journal.pone.0015241.t001. Accessed 10 May 2013
18. MukadiJD, MaherD, HarriesA (2001) Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS 15: 143–152 Available: http://journals.lww.com/aidsonline/Fulltext/2001/01260/Site_of_disease_and_opportunistic_infection.2.aspx. Accessed 10 May 2013.
19. KorenrompEL, GlaziouP, FitzpatrickC, FloydK, HosseiniM, et al. (2012) Implementing the Global Plan to Stop TB, 2011–2015—Optimizing Allocations and the Global Fund's Contribution: A Scenario Projections Study. PLoS ONE 7 (6) e38816 Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0038816. Accessed 10 May 2013
20. World Health Organization (2011) Global tuberculosis control 2011. Available: http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf. Accessed 14 October 2012.
21. GuerraCA, GikandiPW, TatemAJ, NoorAM, SmithDL, et al. (2008) The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med 5: e38 Available: http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0050038. Accessed 10 May 2013
22. Global Fund (2012) Methodology Web Annex. Strategic Investment for Impact: Global Fund Results Report 2012. Available: www.theglobalfund.org/documents/publications/progress_reports/Publication_2012Results_Annext_en/. Accessed 10 May 2013.
23. LengelerC (2004) Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database of Systemic Reviews 2: CD000363 Available: http://www.thecochranelibrary.com/userfiles/ccoch/file/CD000363.pdf. Accessed 10 May 2013
24. RosenS, FoxMP, GillCJ (2007) Patient retention in antiretroviral therapy programs in sub-saharan Africa: a systematic review. PLoS Med 4: e298 Available: http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0040298. Accessed 10 May 2013
25. MarstonM, BecquetR, ZabaB, MoultonLH, GrayG, et al. (2011) Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol 40 (2) 385–396.
26. TassiéJM, BaijalP, VitoriaMA, AlisaladA, CrowleySP, et al. (2010) Trends in retention on antiretroviral therapy in national programs in low-income and middle-income countries. J Acquir Immune Defic Syndr 54: 437–441 Available: http://journals.lww.com/jaids/Fulltext/2010/08010/Trends_in_Retention_on_Antiretroviral_Therapy_in.16.aspx. Accessed 10 May 2013
27. StraetemansM, GlaziouP, BierrenbachAL, SismanidisC, van der WerfMJ (2011) Assessing Tuberculosis Case Fatality Ratio: A Meta-Analysis. PLoS ONE 6 (6) e20755 Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0020755. Accessed 10 May 2013
28. KorenrompEL, ArnoldF, WilliamsBG, NahlenB, SnowRW (2004) Monitoring trends in under-five mortality rates through national birth history surveys. Int J Epid 33: 1293–301.
29. FoxMP, BrennanA, MaskewM, MacPhailP, SanneI (2010) Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med Int Health 15 (4) 405–413.
30. ChiBH, YiannoutsosCT, WestfallAO, NewmanJE, ZhouJ, et al. (2011) Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Med 8: e1001111 Available: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001111. Accessed 10 May 2013
31. BrinkhofMW, DabisF, MyerL, BangsbergDR, BoulleA, et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 86: 559–567 Available: http://www.who.int/bulletin/volumes/86/7/07-044248/en/index.html. Accessed 10 May 2013
32. KranzerK, LewisJJ, FordN, ZeineckerJ, OrrellC, et al. (2010) Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors. J Acquir Immune Defic Syndr 55: e17–23 Available: http://journals.lww.com/jaids/Fulltext/2010/11010/Treatment_Interruption_in_a_Primary_Care.20.aspx. Accessed 10 May 2013
33. NglaziMD, LawnSD, KaplanR, KranzerK, OrrellC, et al. (2011) Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa. J Acquir Immune Defic Syndr 56: e1–8 Available: http://journals.lww.com/jaids/Fulltext/2011/01010/Changes_in_Programmatic_Outcomes_During_7_Years_of.10.aspx. Accessed 10 May 2013
34. BoulleA, Van CutsemG, HilderbrandK, CraggC, AbrahamsM, MatheeS, et al. (2010) Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS 24: 563–72 Available: http://msf.openrepository.com/msf/bitstream/10144/95573/1/Khaylelitsha%20AIDS%202010.pdf. Accessed 10 May 2013
35. MwagombaB, ZachariahR, MassaquoiM, MisindiD, ManziM, et al. (2010) Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals. PLoS ONE 5 (5) e10452 Available: http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010452. Accessed 10 May 2013
36. AungkulanonS, McCarronM, LertiendumrongJ, OlsenSJ, BundhamcharoenK (2012) Infectious disease mortality rates, Thailand, 1958–2009. Emerg Infect Dis 18 (11) Available: http://dx.doi.org/10.3201/eid1811.120637
37. HerbstAJ, CookeGS, BärnighausenT, KanyKanyA, TanserF, et al. (2009) Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ 87 (10) 754–762 Available: http://www.who.int/bulletin/volumes/87/10/08-058982/en/. Accessed 10 May 2013
38. Stoneburner R, Korenromp EL, et al.. (2011) Health impact of HIV and TB interventions in Botswana: initial findings and recommendations to improve empirical evidence and strategic information for program evaluation. Report of UNAIDS, WHO, and Global Fund joint mission, Gaborone, Botswana, 16–24th September 2010. March 2011. Geneva/Gaborone, UNAIDS, WHO HIV/AIDS dept., the Global Fund to fight AIDS, Tuberculosis and Malaria.
39. JahnA, FloydS, CrampinAC, MwaunguluF, MvulaH, et al. (2008) Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet 371 (9624) 1603–1611 Available: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2808%2960693-5/fulltext. Accessed 10 May 2013
40. KorenrompEL (2012) Lives saved from malaria prevention in Africa – evidence to sustain cost-effective gains. Malar J 11: 94 Available: http://www.malariajournal.com/content/11/1/94. Accessed 10 May 2013
41. LimSS, FullmanN, StokesA, RavishankarN, MasiyeF, et al. (2011) Net Benefits: A Multicountry Analysis of Observational Data Examining Associations between Insecticide-Treated Mosquito Nets and Health Outcomes. PLoS Med 8 (9) e1001091 Available: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001091. Accessed 10 May 2013
42. AregawiM, AliAS, Al-mafazyA, MolteniF, KatikitiS, et al. (2011) Reductions in malaria and anemia case and death burden to hospitals following scale-up of malaria control in Zanzibar, 1999–2008. Malar J 10: 46 Available: http://www.malariajournal.com/content/pdf/1475-2875-10-46.pdf. Accessed 10 May 2013
43. MurrayCJ, RosenfeldLC, LimSS, AndrewsKG, ForemanKJ, et al. (2012) Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379 (9814) 413–431 Available: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2812%2960034-8/fulltext. Accessed 10 May 2013
44. LynchM, KorenrompEL, EiseleT, NewbyH, SteketeeR, KachurP, et al. (2012) New global estimates of malaria deaths. Lancet 380 (9841) 559 Available: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2812%2961320-8/fulltext. Accessed 10 May 2013
45. Global Fund (2011) Global Fund Results Fact Sheet, end-2011. Available: http://www.theglobalfund.org/documents/diseases/hivaids/HIV_ARVEnd2011_FactSheet_en/. Accessed 10 May 2013.
46. Kates J, Boortz K, Lief E, Avila C, Gobet B (2010) Financing the Response to AIDS in Low- and Middle-Income Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2009. Kaiser Family Foundation, The Stimson Center, UNAIDS. Available: http://kaiserfamilyfoundation.files.wordpress.com/2013/01/7347-06.pdf. Accessed 14 January 2012.
47. World Health Organization (2011) World Malaria Report 2011. Available: www.who.int/malaria/world_malaria_report_2011/en. Accessed 10 May 2013.
48. McCoyD, KinyuaK (2012) Allocating Scarce Resources Strategically: An Evaluation and Discussion of the Global Fund's Pattern of Disbursement. PLoS ONE 7 (5) e34749 Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0034749. Accessed 10 May 2013
49. Global Fund (2011) Global Fund Results Fact Sheet, mid-2011. Available: http://www.theglobalfund.org/documents/diseases/hivaids/HIV_ARVMid2011_FactSheet_en/. Accessed 10 May 2013.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 10
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Utility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis
- Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV
- Diagnostic Accuracy of Quantitative PCR (Xpert MTB/RIF) for Tuberculous Meningitis in a High Burden Setting: A Prospective Study
- Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study